Zobrazeno 1 - 10
of 77
pro vyhledávání: '"L. Weiselberg"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
L. C. De Marco, D. R. Budman, C. Lathia, P. Amorusi, M. Birkhofer, S. Lichtman, L. Weiselberg, V. Vinciguerra, J. Lovecchio, D. Gal, A. Hoffman, J. Kantrowitz, R. Rastogi
Publikováno v:
Cancer chemotherapy and pharmacology. 36(1)
Zeniplatin, a more water-soluble organoplatinum than cisplatin, was evaluated for clinical pharmacology in the context of a phase II trial in previously treated patients with ovarian carcinoma. A total of 12 patients were given zeniplatin at 120 mg/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1471bac3bfd290fe204c8774c9bc78ce
https://pubmed.ncbi.nlm.nih.gov/7720173
https://pubmed.ncbi.nlm.nih.gov/7720173
Publikováno v:
Cancer Research. 69:3089-3089
Background:Breast cancer cell lines achieve a state of resistance to antiestrogens and to estrogen withdrawal or aromatase inhibitors by utilizing other growth factor pathways to transactivate ERα and undergo estrogen-independent growth. Breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58cbf2ec8d3c139b4da758fd3fed17e2
https://doi.org/10.1158/0008-5472.sabcs-09-3089
https://doi.org/10.1158/0008-5472.sabcs-09-3089
Autor:
W, Kreis, D R, Budman, K, Chan, S L, Allen, P, Schulman, S, Lichtman, L, Weiselberg, M, Schuster, J, Freeman, S, Akerman
Publikováno v:
Leukemia. 5(11)
Thirty two patients with refractory or recurrent acute leukemia or blast crisis of chronic myelocytic leukemia were treated with 1-beta-D-arabinofuranosylcytosine (Ara-C), 100 mg/m2 [group I (n = 15)] or 200 mg/m2 [group II (n = 18)], and tetrahydrou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8b4c63b049c69b6779baaca0ffefa8fb
https://pubmed.ncbi.nlm.nih.gov/1961042
https://pubmed.ncbi.nlm.nih.gov/1961042
Autor:
L, Weiselberg, U, Matulonis, E, McGarvey, B, Roberts, S, Lichtman, S, Allen, V, Vinciguerra, S, Teichberg
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 63(3)
The stereologic characteristics of monocytes from patients with acute nonlymphocytic leukemia containing a monocytic component (FAB M4 and M5), and the monocytes from normal individuals were determined by morphometric analysis. The cells studied were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::77212c16ff1b41e2b536763a4a0dae31
https://pubmed.ncbi.nlm.nih.gov/2395334
https://pubmed.ncbi.nlm.nih.gov/2395334
Publikováno v:
Cancer treatment reports. 67(10)
A phase II trial of mitomycin, vinblastine, and cisplatin was undertaken in 26 patients with non-small cell carcinoma of the lung. A major response rate of 46% was seen in measurable and evaluable disease, with a complete response rate of 12%. Median
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9afccfeba81889f6224862fb7e1c392
https://pubmed.ncbi.nlm.nih.gov/6684988
https://pubmed.ncbi.nlm.nih.gov/6684988
Autor:
W, Kreis, F, Chaudhri, K, Chan, S, Allen, D R, Budman, P, Schulman, L, Weiselberg, J, Freeman, M, Deere, V, Vinciguerra
Publikováno v:
Cancer research. 45(12 Pt 1)
The pharmacokinetic parameters of low dose 1-beta-D-arabinofuranosylcytosine (ara-C) infusions were studied in 11 patients, 6 males and 5 females, with a mean age of 68.5 +/- 13.8 (SD) years. The drug was infused to 4 patients with pre-leukemia (refr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1250f4ef3daa7c33bc795def47e7f8e1
https://pubmed.ncbi.nlm.nih.gov/3864533
https://pubmed.ncbi.nlm.nih.gov/3864533
Publikováno v:
Cancer treatment reports. 66(1)
A role for vinblastine (VBL) in lung cancer has never been clearly defined. Because of recent pharmacokinetic data suggesting a biweekly schedule for VBL and recent antitumor activity shown for vindesine, a phase II trial of divided-dose VBL was init
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e23acd4192f700566af90727d1122261
https://pubmed.ncbi.nlm.nih.gov/7053253
https://pubmed.ncbi.nlm.nih.gov/7053253
Autor:
W, Kreis, K, Chan, D R, Budman, P, Schulman, S, Allen, L, Weiselberg, S, Lichtman, V, Henderson, J, Freeman, M, Deere
Publikováno v:
Cancer research. 48(5)
When 1-beta-D-arabinofuranosylcytosine (ara-C), 25 mg/m2, is infused over 3 h together with tetrahydrouridine (THU) at 10 to 350 mg/m2 to heavily pretreated patients with solid tumors, Michaelis-Menten type kinetic values are observed with leveling o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::21be6a921d757a002bb71d787de11aed
https://pubmed.ncbi.nlm.nih.gov/3342412
https://pubmed.ncbi.nlm.nih.gov/3342412